Hospitalized COVID-19 Patients and Venous Thromboembolism-Reference-Cited by-同舟云学术

Hospitalized COVID-19 Patients and Venous Thromboembolism

Published:2020-07-14 Issue:2 Volume:142 Page:129-132
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Spyropoulos Alex C.¹^ORCID,Weitz Jeffrey I.²

Affiliation:

1. The Institute for Health Innovations and Outcome Research, The Feinstein Institutes for Medical Research and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY (A.C.P.).

2. McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.L.W.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Incidence of thrombotic complications in critically ill ICU patients with COVID-19.;Klok FA;Thromb Res,2020

2. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

3. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients

4. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up [published online April 22, 2020].;Bikdeli B;J Am Coll Cardiol

5. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trial;Journal of Thrombosis and Haemostasis;2024-08

2. The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19;Journal of Cardiovascular Development and Disease;2023-06-03

3. Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry;Thrombosis and Haemostasis;2023-05-05

4. Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis;Clinical and Applied Thrombosis/Hemostasis;2023-01

5. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients;Hematology;2022-12-09